- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05955690
Knowledge and Attitude of Pregnant Women Towards Preeclampsia in Assiut Governorate
Knowledge and Attitude of Pregnant Women Towards Preeclampsia and Its Associated Factors in Assuit University Women's Health Hospital.
Study Overview
Status
Conditions
Detailed Description
Preeclampsia is a pregnancy-related hypertensive disorder that usually occurs after 20 weeks of gestation. It is characterised by hypertension and proteinuria . Preeclampsia is the leading cause of maternal death, complicating about one-tenth of all pregnancies worldwide . It is the second greatest cause of direct maternal death, accounting for 70,000 maternal mortality globally each year .The burden of preeclampsia and eclampsia is most significant in low- and middle-income countries (LMICs), where hypertensive disorders of pregnancy account for 10-15% of maternal deaths.
Early detection of symptoms, rapid presentation to healthcare facilities, and subsequent management with antihypertensive medications, magnesium sulphate, and delivery of the foetus and placenta improve outcomes in pregnancies complicated by preeclampsia and eclampsia . As a result, ANC visits and intrapartum admission are critical chances for patient counselling Despite the essential relationship between women's awareness of preeclampsia and health seeking behaviour, research on this topic is limited, particularly in underdeveloped countries. Even in developed countries, studies in high-income countries show that only half of patients were counselled about preeclampsia signs and symptoms, despite the fact that counselling by healthcare personnel is related to higher patient knowledge. So there is a gap in studying pregnant women's knowledge and attitudes concerning preeclampsia in underdeveloped countries, particularly Egypt, where studies on this topic are scarce.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Asyut, Egypt, 71515
- Assiut University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All pregnant women.
- pregnant women in first, second and third trimester.
- pregnant women who come to receive ANC at Assiut University Hospitals - Women's Health Hospital out patient clinic.
Exclusion Criteria:
- Pregnant women that are unwell to give consent.
- Pregnant women who are already diagnosed by preeclampsia and eclampsia.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of Knowledge of pregnant women about preeclampsia
Time Frame: just after ending the interview in which we filled in questionnaire
|
assessement of knowledge"poor,moderate or good " by answering a structured questionnaire .The women will answer by yes , no or I don't know , A scoring system, where a correct answer attracts a score of one (1) and a wrong or no response (or I don't know) attracts a score of zero (0) was used to scale participants' knowledge of preeclampsia .
The scores were expressed as percentages and Bloom's cut-off point will be employed to classify knowledge of PE into three levels: poor (< 60%), moderate (60-80%) and good (80-100%).high
score means a better outcome .
|
just after ending the interview in which we filled in questionnaire
|
|
Attitude of pregnant women towards preeclampsia
Time Frame: just t after ending the interview in which we filled in questionnaire
|
assessement of attitude ""positive ,neutral or negative " by answering a structured questionnaire.The women will answer by agree ,disagree or unsure , Attitude was reported as positive, neutral and negative when they scored 80-100 %, 60-79 %, and less than 60 % of the attitude assessment questions respectively using the Bloom's cut-off point.
|
just t after ending the interview in which we filled in questionnaire
|
|
Associated factor with knowledge and attitude of pregnant women towards preeclampsia
Time Frame: through study completion, an average of 1 year
|
studying sociodemographic ,medical and obstetric factors that affect knowledge and attitude of pregnant women towards preeclampsia by well structured questionnaire "by the previous scale"
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ahmed M Abbas, MD, Assiut University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- gehadkhalaf
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preeclampsia
-
Comanche BiopharmaRecruitingPreeclampsia | Preterm Preeclampsia | sFlt1 Mediated Preterm PreeclampsiaAustralia
-
MemorialCare Health SystemActive, not recruitingPreeclampsia | Preeclampsia Postpartum | Preeclampsia Severe | Preeclampsia MildUnited States
-
Christiana Care Health ServicesTerminatedPre-Eclampsia | Preeclampsia | Preterm | Preeclampsia Severe | Preeclampsia Second Trimester | Preeclampsia Complicating Childbirth | Preeclampsia PuerperiumUnited States
-
University Medical Centre LjubljanaCompletedPreeclampsia Postpartum | Preeclampsia SevereSlovenia
-
Anna Stanhewicz, PhDActive, not recruiting
-
Cedars-Sinai Medical CenterThermoFisher Scientific Brahms Biomarkers FranceCompletedGestational Hypertension | Preeclampsia Severe | Preeclampsia and Eclampsia | Chronic Hypertension in Obstetric Context | Superimposed Pre-Eclampsia | Preeclampsia MildUnited States
-
Saint Thomas Hospital, PanamaRecruitingPreeclampsia | Severe PreeclampsiaPanama
-
Alexander HarrisonNot yet recruitingPreeclampsia Postpartum | Preeclampsia SevereUnited States
-
Washington University School of MedicineCompletedPreeclampsia Postpartum | Preeclampsia SevereUnited States